A master’s thesis from Karbala Medicine discusses the role of new biomarkers that help diagnose vascular diseases and explain the mechanism of their occurrence

I discussed my master’s thesis in the Clinical Chemistry branch at the College of Medicine, University of Karbala, about the role of new biomarkers in helping to diagnose vascular diseases and explain the mechanism of their occurrence. The thesis submitted by the researcher (Saif Sayhoud Khatib) included the title “New biomarkers that help diagnose vascular diseases and explain the mechanism of their occurrence.”
The discussion committee consisted of:
Professor Dr. Louay Abdel Ismail Al-Hilali, Chairman
Mr. Dr. Haider Subhi Sadiq Al-Haddad, member
A.M.D. Rana Majeed Hamid, member
Mr. Dr. Fadel Jawad Kazem Al-Tom is a supervisor
Mr. Dr. Hanaa Adi Ali Al-Sultani, supervisor

The study aimed to evaluate the association between biochemical markers, such as melanoma inhibitory activity 3 (MIA3), adhesion molecule E-selectin, and cholesteryl ester transfer protein (CETP), as new independent biomarkers with coronary artery disease.

The study also found a clear, statistically significant increase between the patient groups and the healthy group for the study variables (MIA3, E-selectin, and CETP). In addition, fat levels were measured among the study participants, and a noticeable increase was recorded in the patient groups compared to healthy people, which indicates a positive relationship between them and the study variables.